These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16538113)

  • 1. Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations.
    Foucher J; Castéra L; Bernard PH; Adhoute X; Laharie D; Bertet J; Couzigou P; de Lédinghen V
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):411-2. PubMed ID: 16538113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
    Ganne-Carrié N; Ziol M; de Ledinghen V; Douvin C; Marcellin P; Castera L; Dhumeaux D; Trinchet JC; Beaugrand M
    Hepatology; 2006 Dec; 44(6):1511-7. PubMed ID: 17133503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of liver fibrosis by transient elastography (FibroScan) and non-invasive methods in Crohn's disease patients treated with methotrexate.
    Laharie D; Zerbib F; Adhoute X; Boué-Lahorgue X; Foucher J; Castéra L; Rullier A; Bertet J; Couzigou P; Amouretti M; de Lédinghen V
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1621-8. PubMed ID: 16696812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver stiffness measurement in children using FibroScan: feasibility study and comparison with Fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.
    de Lédinghen V; Le Bail B; Rebouissoux L; Fournier C; Foucher J; Miette V; Castéra L; Sandrin L; Merrouche W; Lavrand F; Lamireau T
    J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):443-50. PubMed ID: 18030211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discordance in fibrosis staging between liver biopsy and transient elastography using the FibroScan XL probe.
    Myers RP; Pomier-Layrargues G; Kirsch R; Pollett A; Beaton M; Levstik M; Duarte-Rojo A; Wong D; Crotty P; Elkashab M
    J Hepatol; 2012 Mar; 56(3):564-70. PubMed ID: 22027584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients.
    Kettaneh A; Marcellin P; Douvin C; Poupon R; Ziol M; Beaugrand M; de Lédinghen V
    J Hepatol; 2007 Apr; 46(4):628-34. PubMed ID: 17258346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant liver damage in patients with bleeding disorders and chronic hepatitis C: non-invasive assessment of liver fibrosis using transient elastography.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K; VAN Erpecum KJ; DE Knegt RJ
    J Thromb Haemost; 2007 Jan; 5(1):25-30. PubMed ID: 17239163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.
    Foucher J; Chanteloup E; Vergniol J; Castéra L; Le Bail B; Adhoute X; Bertet J; Couzigou P; de Lédinghen V
    Gut; 2006 Mar; 55(3):403-8. PubMed ID: 16020491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: comparison between M and XL probe of FibroScan®.
    de Lédinghen V; Wong VW; Vergniol J; Wong GL; Foucher J; Chu SH; Le Bail B; Choi PC; Chermak F; Yiu KK; Merrouche W; Chan HL
    J Hepatol; 2012 Apr; 56(4):833-9. PubMed ID: 22173167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of asymptomatic liver fibrosis in alcoholic patients using fibroscan: prospective comparison with seven non-invasive laboratory tests.
    Nguyen-Khac E; Chatelain D; Tramier B; Decrombecque C; Robert B; Joly JP; Brevet M; Grignon P; Lion S; Le Page L; Dupas JL
    Aliment Pharmacol Ther; 2008 Nov; 28(10):1188-98. PubMed ID: 18705692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transient elastography (FibroScan) for non-invasive assessment of liver fibrosis.
    Murtagh J; Foerster V
    Issues Emerg Health Technol; 2006 Sep; (90):1-4. PubMed ID: 17014063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of transient elastography in noninvasive assessment in children's hepatic fibrosis].
    Breton E; Bridoux-Henno L; Guyader D; Daniélou H; Jouan H; Beuchée A; Nousbaum JB; Dabadie A
    Arch Pediatr; 2009 Jul; 16(7):1005-10. PubMed ID: 19446446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive measurement of liver fibrosis: application of the FibroScan in hepatology.
    Verveer C; de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):85-8. PubMed ID: 16782627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Eddowes PJ; Sasso M; Allison M; Tsochatzis E; Anstee QM; Sheridan D; Guha IN; Cobbold JF; Deeks JJ; Paradis V; Bedossa P; Newsome PN
    Gastroenterology; 2019 May; 156(6):1717-1730. PubMed ID: 30689971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors influencing the success rate and stability of transient elastography for liver fibrosis evaluation].
    Li LF; Dai L; Zhang Q; Chen YP; Feng XR; Guo YB; Hou JL
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):595-7. PubMed ID: 18495599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of liver fibrosis with impulse elastography: comparison of Supersonic Shear Imaging with ARFI and FibroScan®.
    Cassinotto C; Lapuyade B; Mouries A; Hiriart JB; Vergniol J; Gaye D; Castain C; Le Bail B; Chermak F; Foucher J; Laurent F; Montaudon M; De Ledinghen V
    J Hepatol; 2014 Sep; 61(3):550-7. PubMed ID: 24815876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpretation of liver stiffness measurement-based approach for the monitoring of hepatitis B patients with antiviral therapy: A 2-year prospective study.
    Liang X; Xie Q; Tan D; Ning Q; Niu J; Bai X; Chen S; Cheng J; Yu Y; Wang H; Xu M; Shi G; Wan M; Chen X; Tang H; Sheng J; Dou X; Shi J; Ren H; Wang M; Zhang H; Gao Z; Chen C; Ma H; Chen Y; Fan R; Sun J; Jia J; Hou J
    J Viral Hepat; 2018 Mar; 25(3):296-305. PubMed ID: 29080299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of liver fibrosis by a noninvasive method of transient elastography and biochemical markers.
    Kawamoto M; Mizuguchi T; Katsuramaki T; Nagayama M; Oshima H; Kawasaki H; Nobuoka T; Kimura Y; Hirata K
    World J Gastroenterol; 2006 Jul; 12(27):4325-30. PubMed ID: 16865773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
    Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
    Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroscan can avoid liver biopsy in Indian patients with chronic hepatitis B.
    Goyal R; Mallick SR; Mahanta M; Kedia S; Shalimar ; Dhingra R; Sharma H; Das P; Datta Gupta S; Panda S; Acharya SK
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1738-45. PubMed ID: 23808910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.